Skip to main content
Premium Trial:

Request an Annual Quote

David Byram

GeneNews announced that it has appointed David Byram as Chief Commercial Officer for its US lab, Innovative Diagnostics Laboratory (IDL). Byram will oversee all of the IDL customer's-facing activities, including sales, client relations, and commercial operations. Prior to joining IDL, Byram was VP, commercial and government affairs for Braeburn Pharmaceuticals. Prior to Braeburn, Byram held positions as senior VP, commercial affairs for Orexo AB/US, US director, public sector for Indivior, and senior director, strategic accounts and public affairs for Janssen Biotech. 

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more